What are the pros and cons of HBsAg loss as the endpoint for treatment? | Jordan Feld, MD, MPH
16:10
Will HBsAg depletion restore HBV specific immunity? | Adam Gehring, PhD
33:14
HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH
23:23
Viral Persistence & Long COVID: Lessons Learned from the First Clinical Trials - Michael Peluso, MD
28:02
Tomorrow and Tomorrow...Studies of the Neuropathogenesis of Long COVID - Serena Spudich, MD
57:03
Alman Sanayisi Neden Çöküyor?
1:36:04
Navigating HBV Treatment and Cure by Starting or Stopping Nucleos(t)ide Analogues (NUC)
35:13
Long COVID: State of the Science and Directions for Policy and Research - Roger Paredes, MD, PhD
29:37